Skip to search formSkip to main contentSkip to account menu

Canrenoate Potassium

Known as: Canrenoate, Potassium, Potassium Canrenoate 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Introduction: Recent clinical studies have reported the potential benefit of an early mineralocorticoid receptor (MR) blockade… 
2004
2004
SummaryFive healthy male volunteers received canrenoate-K 200 mg (Sincomen® pro injectione) by intravenous injection and one week… 
Review
2002
Review
2002
1985
1985
We have established a sensitive and specific radioreceptor assay for androgen receptor active materials in plasma, using… 
1984
1984
The possibility that efferent factors in addition to aldosterone and plasma K may mediate the renal response to large variations… 
1977
1977
Twenty patients receiving a constant maintenance therapy of digoxin preparations were selected, and daily plasma digoxin… 
1976
1976
The pharmacological activity of single doses of the two aldosterone antagonists, potassium canrenoate and spironolactone, was… 
Highly Cited
1976
Highly Cited
1976
Effects of spironolactone, canrenone and canrenoate-K on adrenal cytochrome P450 (P450) and corticosteroid biosynthesis were… 
1972
1972
Potassium canrenoate, a steroidal compound and a specific antagonist of aldosterone, had (1) a potent protective effect against… 
1971
1971
The metabolism of intravenously administered radioactive potassium canrenoate (SC-14266-3H) was studied in three men. Within 5…